How has been the historical performance of Tulasee Bio-Eth.?

Answer:The historical performance of Tulasee Bio-Eth shows a consistent trend of zero net sales and total operating income from March 2019 to March 2025. The company has not generated any revenue during this period, and its total expenditure has remained minimal, primarily consisting of other expenses that slightly decreased from 0.57 crore in March 2021 to 0.13 crore in March 2025. Operating profit, excluding other income, has consistently been negative, with losses ranging from -0.17 crore in March 2019 to -0.13 crore in the latest fiscal year. Profit before tax and profit after tax have mirrored this trend, with losses reported each year except for a brief positive profit in March 2021. The company's equity capital has remained stable at 5.84 crore, while reserves have shown a negative trend, increasing from -4.93 crore in March 2019 to -5.14 crore in March 2025. The total liabilities have slightly increased from 8.18 crore in March 2020 to 8.22 crore in March 2025, primarily driven by long-term borrowings, which have risen from 6.66 crore to 7.38 crore over the same period. The book value per share has decreased from 2.37 in March 2020 to 1.20 in March 2025, indicating a decline in shareholder value.

Breakdown:
Tulasee Bio-Eth has consistently reported zero net sales and total operating income from March 2019 through March 2025, indicating a lack of revenue generation. The company's total expenditure has remained low, primarily due to minimal other expenses, which have decreased over the years. Operating profit has been negative throughout this period, with losses improving slightly from -0.57 crore in March 2021 to -0.13 crore in March 2025. The company reported profits in March 2021 but has since returned to losses. Equity capital has remained unchanged, while reserves have worsened, reflecting increasing negative values. Total liabilities have seen a slight increase, driven by rising long-term borrowings, which have grown steadily. The book value per share has also declined, highlighting a decrease in shareholder value over the years.